Overview
Portfolio
More
Sneakpeeki
Seoul, South Korea
Invests in early-stage bio and healthcare technology companies, providing strategic support leveraging deep industry experience.
Portfolio
8+
Employees
5+
Founded
2019
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
Asia
Sources
Sneakpeeki
Invests in early-stage bio and healthcare technology companies, providing strategic support leveraging deep industry experience.
Portfolio
8+
Employees
5+
Founded
2019
AUM
N/A
Showing 8 of 8 matched portfolio companies
E INC enhances the automotive purchasing process by providing a digital platform that streamlines wholesale and retail transactions through advanced technology and data analytics. This approach addresses inefficiencies in the automotive ecosystem, enabling faster and more flexible business operations for dealers and consumers.
eo is a sports technology lab that employs physiological data analysis and adaptive training methodologies to enhance athletic performance and reduce injury risk. By implementing advanced recovery protocols, eo enables athletes to optimize their recovery and increase resilience to physical stressors.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
The startup develops bioidentical therapeutics aimed at reeducating dysregulated immune systems to facilitate functional tissue recovery. Their expertise spans therapeutic areas including infectious diseases and metabolic disorders, enabling clients to effectively manage inflammatory diseases and syndromes.
Founded 2017
1000+
Approximate amount of employees
Funding: $750.0K
Rough estimate of the amount of funding raised
Funding: $750.0K
Rough estimate of the amount of funding raised
The startup develops cytokine-antibody fusion proteins to create first-in-class immuno-oncology drugs that specifically target advanced solid tumors. This approach aims to enhance the efficacy of cancer immunotherapy by overcoming the limitations of existing treatment options.
Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
The startup offers a fully digital UPI credit card that provides guaranteed cashbacks and rewards for every transaction, allowing users to make small payments without minimum spending and convert larger purchases into easy EMIs. This platform addresses the need for a seamless payment solution that combines the convenience of UPI with the benefits of credit card perks, all while ensuring no hidden fees.
Ro operates a telehealth platform that provides online clinics for weight loss, sexual health, hair restoration, and fertility management using clinically proven treatments and prescription medications. The service eliminates the need for insurance and offers free, discreet shipping, making healthcare accessible and convenient for over 2 million members.
Tera provides a carbon-negative technology that captures CO2 from industrial off-gas emissions and converts it into value-added chemicals, enabling businesses to generate revenue from their exhaust streams. The platform also offers real-time emissions monitoring and data-driven recommendations to accelerate decarbonization in supply chains.
Funding: $250.0K
Rough estimate of the amount of funding raised
Funding: $250.0K
Rough estimate of the amount of funding raised